Behavioral Changes of Paranoia Associated with Atorvastatin;Hemolytic-Uremic Syndrome Associated with Gemcitabine;Daptomycin-Induced Acute Renal Failure and Hepatic Toxicity;Drug-Induced Liver Disease Related to Citalopram;Unexpected Acute Hepatic Injury in Patients Treated Repeatedly with Ketoconazole;Acute Hepatotoxicity Seen with Lamotrigine;Anticholinergic Adverse Effects in Elderly Patients

Abstract

The purpose of this feature is to heighten awareness of specific adverse drug reactions (ADRs), discuss methods of prevention, and promote reporting of ADRs to the Food and Drug Administration's (FDA) MedWatch program (800-FDA-1088). If you have reported an interesting preventable ADR to MedWatch, please consider sharing the account with our readers. Write to Dr. Shuster at ISMP, 1800 Byberry Road, Suite 810, Huntingdon Valley, PA 19006 (phone: [phone]; fax: [phone]; e-mail: [e-mail]). Your report will be published anonymously unless otherwise requested. This feature is provided by the Institute for Safe Medication Practices (ISMP) in cooperation with the FDA's MedWatch Program and Temple University School of Pharmacy. ISMP is an FDA MedWatch partner.